ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

HEW Money Bills Mark Up Set May 26

May 20, 1977

Health Professional Training Needs Improvement, IOM Says.

July 4, 2003

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013